Domov › Velika depresivna motnja › Pennsylvania
Klinične študije za Velika depresivna motnja v Pennsylvania
27 študij za Velika depresivna motnja išče udeležence na lokacijah v Pennsylvania.
Mesta v Pennsylvania
Uradno besedilo študije (angleško)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Adams Clinical Philadelphia, Philadelphia
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- Suburban Research Associates, West Chester
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07775300Precision Depression Adalimumab Trial
- University of Pennsylvania, Philadelphia
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07845604Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- University of Pennsylvania, Philadelphia
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- University of Pennsylvania - Perelman School of Medicine, Philadelphia
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Adams Clinical Philadelphia, Philadelphia
- Flourish Research Philadelphia, Philadelphia
Vključevanje udeležencevFaza 3
Starost 18–85 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Allentown
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07065240Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
- University of Pennsylvania, Philadelphia
Vključevanje udeležencevZgodnja faza 1
Starost 25–65 · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT06788249Decoding and Modulating Affective Brain States
- University of Pennsylvania, Philadelphia
Vključevanje udeležencevOmenja plačilo za udeležence
Starost 18–65 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT05437705A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Allentown
- Draig Clinical Site, Media
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Pennsylvania Hospital, Philadelphia
Vključevanje udeležencev
Starost 22–70 · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Media
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT07300969Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 14. avg. 2026 · NCT07226232A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Adams Clinical Philadelphia, Philadelphia
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07592689NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Philadelphia
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT06963021A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Suburban Research Associates, Media
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Lehigh Center For Clinical Research, Allentown
- Adams Clinical - Philadelphia, Philadelphia
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Lehigh Center for Clinical Research, Allentown
Vključevanje udeležencevFaza 2
Starost 18–64 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Lehigh Center for Clinical Research, Allentown
- Adams Clinical, Philadelphia
Vključevanje udeležencevFaza 2
Starost 18–64 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT07115329A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Philadelphia
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Philadelphia
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT06966401Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments
- Bellefield Towers, Pittsburgh
Vključevanje udeležencev
Starost 18–55 · Vsi spoli · Posodobljeno 22. maj 2026 · NCT06976840Triage Survey for Psychiatry Research Eligibility
- Adams Clinical, Philadelphia, Philadelphia
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 20. maj 2026 · NCT05800925A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Scranton Medical Institute, LLC, Moosic
- University of Pennsylvania, Philadelphia
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 11. maj 2026 · NCT06524830Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
- University of Pittsburgh, Pittsburgh
Vključevanje udeležencev
Starost 18–55 · Vsi spoli · Posodobljeno 4. mar. 2026 · NCT05703256Taking Action for College Students
- Temple University, Philadelphia
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 29. dec. 2025 · NCT06700902Neurofeedback to Treat Depression - 2
- Center for Neuromodulation in Depression and Stress, Philadelphia
Vključevanje udeležencev
Starost 18–65 · Vsi spoli · Posodobljeno 4. dec. 2025 · NCT07159061Study of ALTO-300 in MDD
- Site 216, Allentown
- Site 350, Media
- Site 352, Moosic
Vključevanje udeležencevFaza 2
Starost 18–70 · Vsi spoli · Posodobljeno 24. jul. 2025 · NCT05922878Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.